Dynamic regulation of H3K9 modifications in cancer: pathogenesis and targeted therapies
Open Access
- 16 October 2026
- journal article
- review article
- Published by Springer Nature in Biomarker Research
- Vol. 14 (1) , 143
Abstract
Post-translational modifications (PTMs) of histone H3 at lysine 9 (H3K9) contribute to chromatin homeostasis and transcriptional regulation and have been iKeywords
Funding Information
- National Natural Science Foundation of China (82300212)
- National Natural Science Foundation of China (82403198)
This publication has 478 references indexed in Scilit:
- Targeting HDAC and PARP Enhances STING‐Dependent Antitumor Immunity in STING‐Deficient TumorAdvanced Science, 2025
- Short‐chain acyl post‐translational modifications in cancers: Mechanisms, roles, and therapeutic implicationsCancer Communications, 2025
- Histone H3K9 Lactylation Confers Temozolomide Resistance in Glioblastoma via LUC7L2‐Mediated MLH1 Intron RetentionAdvanced Science, 2024
- AF9 sustains glycolysis in colorectal cancer via H3K9ac‐mediated PCK2 and FBP1 transcriptionClinical and Translational Medicine, 2023
- Histone lysine methyltransferase SETDB2 suppresses NRF2 to restrict tumor progression and modulates chemotherapy sensitivity in lung adenocarcinomaCancer Medicine, 2022
- Structure‐Guided Discovery of a Potent and Selective Cell‐Active Inhibitor of SETDB1 Tudor DomainAngewandte Chemie International Edition, 2021
- A phase I/II study of the combination of panobinostat and carfilzomib in patients with relapsed or relapsed/refractory multiple myeloma: Final analysis of second dose‐expansion cohortAmerican Journal of Hematology, 2021
- Conformational Dynamics Underlies Different Functions of Human KDM7 Histone DemethylasesChemistry – A European Journal, 2019
- Structure and Function of Histone H3 Lysine 9 Methyltransferases and DemethylasesChemBioChem, 2011
- Design, Synthesis, and Biological Evaluation of a Small‐Molecule Inhibitor of the Histone Acetyltransferase Gcn5Angewandte Chemie International Edition, 2004